Table 2. Bivariate relationships of biologic markers with hemolytic component and hemoglobin oxygen saturation in patients with sickle cell disease [Pearson correlation].
Hemolytic component (N = 225) | Hemoglobin O2 saturation (N = 233) | Hemoglobin concentration (N = 237) | ||||
R | P | R | P | R | P | |
Inflammatory markers | ||||||
Interleukin-6 (pg/ml, natural log) | 0.07 | 0.3 | −0.10 | 0.1 | −0.08 | 0.2 |
Interleukin-8 (pg/ml, natural log) | 0.21 | 0.001* | −0.20 | 0.002* | −0.12 | 0.1 |
Interferon-γ (pg/ml, natural log) | 0.15 | 0.021 | −0.14 | 0.034 | −0.22 | 0.0006* |
Monocyte chemoattractant protein-1 (pg/ml, natural log) | −0.07 | 0.3 | 0.01 | 0.9 | −0.05 | 0.4 |
Tumor necrosis factor-α (pg/ml, natural log) | 0.17 | 0.012 | −0.13 | 0.049 | −0.19 | 0.004* |
Interleukin-10 (pg/ml, natural log) | 0.15 | 0.026 | −0.18 | 0.006 | −0.14 | 0.021 |
RANTES (ng/ml, natural log) | −0.03 | 0.7 | 0.04 | 0.6 | 0.17 | 0.007 |
Angiogenic markers | ||||||
Fibroblast growth factor (basic) (pg/ml, sq. root) | 0.15 | 0.022 | −0.19 | 0.004* | −0.24 | 0.0001* |
PDGF- BB (ng/ml, square root) | 0.15 | 0.028 | −0.15 | 0.025 | −0.08 | 0.2 |
VEGF (pg/ml, natural log) | 0.17 | 0.012 | −0.16 | 0.016 | −0.19 | 0.003* |
Statistically significant after adjustment for multiple comparisons.